Keisuke Okamoto

1.3k total citations
55 papers, 435 citations indexed

About

Keisuke Okamoto is a scholar working on Pathology and Forensic Medicine, Nephrology and Immunology. According to data from OpenAlex, Keisuke Okamoto has authored 55 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Nephrology and 8 papers in Immunology. Recurrent topics in Keisuke Okamoto's work include Chemotherapy-induced organ toxicity mitigation (7 papers), Schizophrenia research and treatment (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Keisuke Okamoto is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (7 papers), Schizophrenia research and treatment (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Keisuke Okamoto collaborates with scholars based in Japan, United States and Netherlands. Keisuke Okamoto's co-authors include Katsuya Narumi, Masaki Kobayashi, Ken Iseki, Yoshitaka Saito, Ayako Furugen, Atsushi Hirano, Takehiro Yamada, Josefina F. Llena, Chihiro Kaneko and Shunichi Sasaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Keisuke Okamoto

46 papers receiving 425 citations

Peers

Keisuke Okamoto
Keisuke Okamoto
Citations per year, relative to Keisuke Okamoto Keisuke Okamoto (= 1×) peers Joaquı́n V. Rodrı́guez

Countries citing papers authored by Keisuke Okamoto

Since Specialization
Citations

This map shows the geographic impact of Keisuke Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Okamoto more than expected).

Fields of papers citing papers by Keisuke Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Okamoto. The network helps show where Keisuke Okamoto may publish in the future.

Co-authorship network of co-authors of Keisuke Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Okamoto. A scholar is included among the top collaborators of Keisuke Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Okamoto. Keisuke Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narumi, Katsuya, Yoshitaka Saito, Ayako Furugen, et al.. (2025). Validity and Utility of a Risk Prediction Model for Wound Infection After Lower Third Molar Surgery. Oral Diseases. 31(6). 1922–1931.
3.
Eriguchi, Masahiro, Hiroyuki Tamaki, Mari Nakanishi, et al.. (2025). Fibroblast Growth Factor 23, Urinary Phosphate, and Risk of Progression of CKD. Clinical Journal of the American Society of Nephrology. 21(2). 201–210.
4.
Okamoto, Keisuke, et al.. (2025). Effect of Acid Suppressants on Adverse Events of Immune Checkpoint Inhibitors Using Real-world Databases. Anticancer Research. 45(8). 3287–3293.
5.
Yamaguchi, Atsushi, Yoshitaka Saito, Keisuke Okamoto, et al.. (2024). Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor Monotherapy. In Vivo. 38(6). 2886–2896. 1 indexed citations
6.
Okamoto, Keisuke, Yoshitaka Saito, Atsushi Yamaguchi, Katsuya Narumi, & Masaki Kobayashi. (2024). Relationship between magnesium dosage and the preventive effect on cisplatin-induced nephrotoxicity: meta-analysis and meta-regression analysis. International Journal of Clinical Oncology. 29(12). 1817–1824. 3 indexed citations
7.
Sano, Fumiya, et al.. (2024). Effect of Lurasidone on Life Engagement in Schizophrenia: Post-Hoc Analysis of the JEWEL Study. Neuropsychiatric Disease and Treatment. Volume 20. 1453–1463. 1 indexed citations
8.
Okamoto, Keisuke, Yoshitaka Saito, Atsushi Yamaguchi, Yoh Takekuma, & Mitsuru Sugawara. (2023). Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis. International Journal of Clinical Oncology. 28(10). 1343–1353. 3 indexed citations
9.
Eriguchi, Masahiro, Hiroyuki Tamaki, Kaori Tanabe, et al.. (2023). Differential impact of glomerular and tubule-interstitial histological changes on kidney outcome between non-proteinuric and proteinuric diabetic nephropathy. Clinical and Experimental Nephrology. 28(4). 282–292. 3 indexed citations
10.
Saito, Yoshitaka, Tatsuhiko Sakamoto, Yoh Takekuma, et al.. (2022). Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis. Scientific Reports. 12(1). 21819–21819. 2 indexed citations
11.
Iyo, Masaomi, Jun Ishigooka, Masatoshi Nakamura, et al.. (2021). Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study. Neuropsychiatric Disease and Treatment. Volume 17. 2683–2695. 9 indexed citations
12.
Yamaguchi, Atsushi, Yoshitaka Saito, Keisuke Okamoto, et al.. (2021). Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis. Supportive Care in Cancer. 29(12). 7747–7753. 22 indexed citations
13.
Okamoto, Keisuke, Yoshitaka Saito, Katsuya Narumi, et al.. (2021). Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells. Toxicology in Vitro. 74. 105155–105155. 17 indexed citations
14.
Itami, Hiroe, Shigeo Hara, Ken‐ichi Samejima, et al.. (2020). Complement activation is associated with crescent formation in IgA nephropathy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(4). 565–572. 22 indexed citations
15.
Saito, Yoshitaka, Keisuke Okamoto, Masaki Kobayashi, et al.. (2017). Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration. Life Sciences. 189. 18–22. 20 indexed citations
16.
Matsui, Masaru, Ken‐ichi Samejima, Yukiji Takeda, et al.. (2015). Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients. American Journal of Nephrology. 42(2). 117–125. 3 indexed citations
17.
Okamoto, Keisuke, et al.. (2005). Effects of a collagenolytic cell wall component from Fusobacterium necrophorum subsp. necrophorum on rabbit tissue-culture cells. The Veterinary Journal. 171(2). 380–382. 1 indexed citations
18.
Nakamura, Fuminori, et al.. (1998). Immunosuppressive and antiparasitic effects of cyclosporin A on Hymenolepis nana infection in mice. International Journal for Parasitology. 28(4). 579–588. 7 indexed citations
19.
Okamoto, Keisuke. (1969). Effect of cortisone on acquired resistance to Hymenolepis nana in mice.. Kiseichūgaku zasshi. 18(6). 6 indexed citations
20.
Okamoto, Keisuke. (1968). Effect of neonatal thymectomy on acquired resistance to Hymenolepis nana in mice.. Kiseichūgaku zasshi. 17(1). 53–59. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026